| Version |
2.5 |
| Creation Date |
2005-06-13 13:24:05 |
| Update Date |
2009-02-19 16:04:02 |
| Primary Accession Number |
DB00895 |
| Secondary Accession Number |
|
| Name |
Benzylpenicilloyl Polylysine |
| Drug Type |
|
| Description |
Benzylpenicilloyl Polylysine is used as a skin-testing reagent to detect immunoglobulin E antibodies in people with a history of penicillin allergy. The quantitation of in vitro IgE antibodies to the benzylpenicilloyl determinant is a useful tool for evaluating allergic subjects. |
| Synonyms |
Not Available |
| Brand Names |
- Pre-pen
|
| Brand Mixtures |
Not Available |
| Chemical IUPAC Name |
2-[2-[(6-hydroxy-6-oxohexyl)amino]-2-oxo-1-[(2-phenylacetyl)amino]ethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid |
| Chemical Formula |
C22H31N3O6S |
| Chemical Structure |
 |
| CAS Registry Number |
2642-55-9 |
| InChI Identifier |
InChI=1/C22H31N3O6S/c1-22(2)18(21(30)31)25-20(32-22)17(19(29)23-12-8-4-7-11-16(27)28)24-15(26)13-14-9-5-3-6-10-14/h3,5-6,9-10,17-18,20,25H,4,7-8,11-13H2,1-2H3,(H,23,29)(H,24,26)(H,27,28)(H,30,31)/f/h23-24,27,30H |
| InChI Key |
KJABUVRFCPPJPD-KDAFFUTBCU |
| KEGG Drug |
Not Available |
| KEGG Compound |
Not Available |
| PubChem Compound |
119212  |
| PubChem Substance |
695873  |
| ChEBI ID |
Not Available |
| PharmGKB ID |
Not Available |
| HET ID |
Not Available |
| GenBank ID |
Not Available |
| Drug ID Number [DIN] |
Not Available |
| RxList Link |
Not Available |
| PDRhealth Link |
Not Available |
| Wikipedia Link |
Not Available |
| FDA Label |
Not Available |
| Material Safety Data Sheet (MSDS) |
Not Available |
| Synthesis Reference |
Not Available |
| Average Molecular Weight |
465.5630 |
| Monoisotopic Molecular Weight |
465.1934 |
| State |
Solid |
| Melting Point |
Not Available |
| Experimental Water Solubility |
Not Available
Source: PhysProp
|
| Predicted Water Solubility |
3.16e-02 mg/mL
Calculated using ALOGPS
|
| Experimental LogP/Hydrophobicity |
-0.8
Source: PhysProp
|
| Predicted LogP |
0.45
Calculated using ALOGPS
|
| Experimental LogS |
Not Available |
| Predicted LogS |
-4.17
Calculated using ALOGPS
|
| Experimental Caco2 Permeability |
Not Available |
| pKa/Isoelectric Point |
Not Available |
| Mass Spectrum |
Not Available
|
| MOL File |
Show | Download  |
| SDF File |
Show | Download  |
| PDB File |
Show | Download  |
| 2D Structure |
|
| 3D Structure |
|
| Experimental PDB ID |
Not Available |
| Isomeric SMILES |
CC1(C)S[C@@H](N[C@@H]1C(O)=O)[C@H](NC(=O)CC1=CC=CC=C1)C(=O)NCCCCCC(O)=O |
| Canonical SMILES |
CC1(C)SC(NC1C(O)=O)C(NC(=O)CC1=CC=CC=C1)C(=O)NCCCCCC(O)=O |
| Drug Category |
Not Available |
| ATC Codes |
Not Available |
| AHFS Codes |
|
| Indication |
For use as a adjunct in assessing the risk of administering penicillin (benzylpenicillin or penicillin G). |
| Pharmacology |
Benylpenicilloyl polylysine is penicilloyl bound to polylysine and is considered to be the major determinant of penicillin metabolism; it is used as a skin-testing reagent to detect immunoglobulin E antibodies in people with a history of penicillin allergy. If skin testing using benzylpenicilloyl and penicillin G (as the sole source of minor determinants) is negative, approximately 97% of patients with a negative skin test will tolerate penicillin. |
| Mechanism of Action |
The skin test for penicillin demonstrates the presence or absence of specific IgE antibodies to major and minor penicillin determinants. IgE antibodies to major determinants can be detected by using benzylpenicilloyl polylysine. A penicillin skin test predicts only the presence of IgE antibodies for the major or minor penicillin determinants at the time of application and does not predict the future development of IgE-mediated reactions during subsequent courses of penicillin. Benzylpenicilloyl polylysine reacts specifically with penicilloyl skin sensitizing antibodies (reagins) to produce immediate wheal and flare reactions which may reflect increased risk of allergic reactions to subsequent penicillin therapy. |
| Absorption |
Not Available |
| Toxicity |
Symptoms of overdose include urticaria, generalized pruritus, local swelling, generalized flushing, anaphylaxis, bronchospasm, fainting and maculopapular eruption. |
| Protein Binding |
Not Available |
| Biotransformation |
Not Available |
| Half Life |
Not Available |
| Dosage Forms |
| Form |
Route |
| Liquid |
Intradermal |
|
| Patient Information |
Not Available |
| Contraindications |
Show  |
| Interactions |
Not Available |
| Drug Interactions |
Not Available
|
| Food Interactions |
Not Available
|
| Pathways |
Not Available
|
| General References |
- [PubMed
]
|
| Organisms Affected |
|
| Targets |
- High affinity immunoglobulin epsilon receptor subunit alpha
- High affinity immunoglobulin epsilon receptor gamma-subunit
|
|
Drug Target 1
[top]
|
| Target 1 ID |
18 |
| Target 1 Name |
High affinity immunoglobulin epsilon receptor subunit alpha |
| Target 1 Synonyms |
- Fc-epsilon RI-alpha
- FcERI
- High affinity immunoglobulin epsilon receptor subunit alpha precursor
- IgE Fc receptor, alpha-subunit
|
| Target 1 Gene Name |
FCER1A |
| Target 1 Protein Sequence |
>High affinity immunoglobulin epsilon receptor alpha-subunit precursor
MAPAMESPTLLCVALLFFAPDGVLAVPQKPKVSLNPPWNRIFKGENVTLTCNGNNFFEVS
STKWFHNGSLSEETNSSLNIVNAKFEDSGEYKCQHQQVNESEPVYLEVFSDWLLLQASAE
VVMEGQPLFLRCHGWRNWDVYKVIYYKDGEALKYWYENHNISITNATVEDSGTYYCTGKV
WQLDYESEPLNITVIKAPREKYWLQFFIPLLVVILFAVDTGLFISTQQQVTFLLKIKRTR
KGFRLLNPHPKPNPKNN
|
| Target 1 Number of Residues |
261 |
| Target 1 Molecular Weight |
29596 |
| Target 1 Theoretical pI |
6.67 |
| Target 1 GO Classification |
Not Available |
| Target 1 General Function |
Not Available |
| Target 1 Specific Function |
Binds to the Fc region of immunoglobulins epsilon. High affinity receptor. Responsible for initiating the allergic response. Binding of allergen to receptor-bound IgE leads to cell activation and the release of mediators (such as histamine) responsible for the manifestations of allergy. The same receptor also induces the secretion of important lymphokines |
| Target 1 Pathways |
Not Available
|
| Target 1 Reactions |
Not Available |
| Target 1 Pfam Domain Function |
|
| Target 1 Signals |
|
| Target 1 Transmembrane Regions |
|
| Target 1 Essentiality |
Non-Essential |
| Target 1 GenBank ID Protein |
31318  |
| Target 1 UniProtKB/Swiss-Prot ID |
P12319  |
| Target 1 UniProtKB/Swiss-Prot Entry Name |
FCERA_HUMAN  |
| Target 1 PDB ID |
1RPQ  |
| Target 1 PDB File |
Show |
| Target 1 3D Structure |
|
| Target 1 Cellular Location |
- Membrane
- single-pass type I membrane protein
|
| Target 1 Gene Sequence |
>774 bp
ATGGCTCCTGCCATGGAATCCCCTACTCTACTGTGTGTAGCCTTACTGTTCTTCGCTCCA
GATGGCGTGTTAGCAGTCCCTCAGAAACCTAAGGTCTCCTTGAACCCTCCATGGAATAGA
ATATTTAAAGGAGAGAATGTGACTCTTACATGTAATGGGAACAATTTCTTTGAAGTCAGT
TCCACCAAATGGTTCCACAATGGCAGCCTTTCAGAAGAGACAAATTCAAGTTTGAATATT
GTGAATGCCAAATTTGAAGACAGTGGAGAATACAAATGTCAGCACCAACAAGTTAATGAG
AGTGAACCTGTGTACCTGGAAGTCTTCAGTGACTGGCTGCTCCTTCAGGCCTCTGCTGAG
GTGGTGATGGAGGGCCAGCCCCTCTTCCTCAGGTGCCATGGTTGGAGGAACTGGGATGTG
TACAAGGTGATCTATTATAAGGATGGTGAAGCTCTCAAGTACTGGTATGAGAACCACAAC
ATCTCCATTACAAATGCCACAGTTGAAGACAGTGGAACCTACTACTGTACGGGCAAAGTG
TGGCAGCTGGACTATGAGTCTGAGCCCCTCAACATTACTGTAATAAAAGCTCCGCGTGAG
AAGTACTGGCTACAATTTTTTATCCCATTGTTGGTGGTGATTCTGTTTGCTGTGGACACA
GGATTATTTATCTCAACTCAGCAGCAGGTCACATTTCTCTTGAAGATTAAGAGAACCAGG
AAAGGCTTCAGACTTCTGAACCCACATCCTAAGCCAAACCCCAAAAACAACTGA
|
| Target 1 GenBank Gene ID |
|
| Target 1 GeneCard ID |
FCER1A  |
| Target 1 GenAtlas ID |
FCER1A  |
| Target 1 HGNC ID |
HGNC:3609  |
| Target 1 Chromosome Location |
1 |
| Target 1 Locus |
1q23 |
| Target 1 SNPs |
SNPJam Report  |
| Target 1 General References |
- Padlan EA, Helm BA: A modeling study of the alpha-subunit of human high-affinity receptor for immunoglobulin-E. Receptor. 1992 Summer;2(2):129-44. [PubMed
]
- Shimizu A, Tepler I, Benfey PN, Berenstein EH, Siraganian RP, Leder P: Human and rat mast cell high-affinity immunoglobulin E receptors: characterization of putative alpha-chain gene products. Proc Natl Acad Sci U S A. 1988 Mar;85(6):1907-11. [PubMed
]
- Kochan J, Pettine LF, Hakimi J, Kishi K, Kinet JP: Isolation of the gene coding for the alpha subunit of the human high affinity IgE receptor. Nucleic Acids Res. 1988 Apr 25;16(8):3584. [PubMed
]
- Yagi S, Yanagida M, Tanida I, Hasegawa A, Okumura K, Ra C: High-level expression of the truncated alpha chain of human high-affinity receptor for IgE as a soluble form by baculovirus-infected insect cells. Biochemical characterization of the recombinant product. Eur J Biochem. 1994 Mar 1;220(2):593-8. [PubMed
]
|
| Target 1 Drug References |
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed
]
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed
]
|
|
Drug Target 2
[top]
|
| Target 2 ID |
55 |
| Target 2 Name |
High affinity immunoglobulin epsilon receptor gamma-subunit |
| Target 2 Synonyms |
- Fc-epsilon RI-gamma
- FceRI gamma
- High affinity immunoglobulin epsilon receptor gamma-subunit precursor
- IgE Fc receptor gamma-subunit
|
| Target 2 Gene Name |
FCER1G |
| Target 2 Protein Sequence |
>High affinity immunoglobulin epsilon receptor gamma-subunit precursor
MIPAVVLLLLLLVEQAAALGEPQLCYILDAILFLYGIVLTLLYCRLKIQVRKAAITSYEK
SDGVYTGLSTRNQETYETLKHEKPPQ
|
| Target 2 Number of Residues |
87 |
| Target 2 Molecular Weight |
9668 |
| Target 2 Theoretical pI |
7.24 |
| Target 2 GO Classification |
|
Function
|
signal transducer activity
receptor activity
transmembrane receptor activity |
|
Process
|
cellular process
cell communication
signal transduction
cell surface receptor linked signal transduction |
|
Component
|
cell
membrane |
|
| Target 2 General Function |
Involved in immune function |
| Target 2 Specific Function |
The gamma subunit has a critical role in allowing the IgE Fc receptor to reach the cell surface |
| Target 2 Pathways |
Not Available
|
| Target 2 Reactions |
Not Available |
| Target 2 Pfam Domain Function |
|
| Target 2 Signals |
|
| Target 2 Transmembrane Regions |
|
| Target 2 Essentiality |
Non-Essential |
| Target 2 GenBank ID Protein |
182488  |
| Target 2 UniProtKB/Swiss-Prot ID |
P30273  |
| Target 2 UniProtKB/Swiss-Prot Entry Name |
FCERG_HUMAN  |
| Target 2 PDB ID |
Not Available |
| Target 2 Cellular Location |
- Membrane
- single-pass type I membrane protein
|
| Target 2 Gene Sequence |
>261 bp
ATGATTCCAGCAGTGGTCTTGCTCTTACTCCTTTTGGTTGAACAAGCAGCGGCCCTGGGA
GAGCCTCAGCTCTGCTATATCCTGGATGCCATCCTGTTTCTGTATGGAATTGTCCTCACC
CTCCTCTACTGTCGACTGAAGATCCAAGTGCGAAAGGCAGCTATAACCAGCTATGAGAAA
TCAGATGGTGTTTACACGGGCCTGAGCACCAGGAACCAGGAGACTTACGAGACTCTGAAG
CATGAGAAACCACCACAGTAG
|
| Target 2 GenBank Gene ID |
|
| Target 2 GeneCard ID |
FCER1G  |
| Target 2 GenAtlas ID |
FCER1G  |
| Target 2 HGNC ID |
HGNC:3611  |
| Target 2 Chromosome Location |
1 |
| Target 2 Locus |
1q23 |
| Target 2 SNPs |
SNPJam Report  |
| Target 2 General References |
- Kuster H, Thompson H, Kinet JP: Characterization and expression of the gene for the human Fc receptor gamma subunit. Definition of a new gene family. J Biol Chem. 1990 Apr 15;265(11):6448-52. [PubMed
]
|
| Target 2 Drug References |
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed
]
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed
]
|